COVID-19-induced extracorporeal circulation coagulation during continuous renal replacement therapy: A cross-sectional study

被引:1
作者
Wu, Dibin [1 ]
Yang, Guang [1 ,2 ]
Dai, Shien [1 ]
Khan, Abbas [3 ]
Liang, Wei [1 ]
Wang, Aihong [1 ]
机构
[1] Peking Univ Shenzhen Hosp, Div Renal Med, Shenzhen 518036, Peoples R China
[2] Shenzhen Clin Res Ctr Urol & Nephrol, Shenzhen, Peoples R China
[3] Univ Home Econ Lahore Pakistan, Dept Nutr & Hlth Promot, Lahore, Pakistan
关键词
clotting; coagulation; COVID-19; CRRT; hemodialysis; DIALYSIS;
D O I
10.1097/MD.0000000000040187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
After the control policies of the COVID-19 epidemic were lifted in China from December 5th, 2022, there was an increase in the demand for hemodialysis and continuous renal replacement therapy (CRRT) at our center, and patients experienced hypercoagulable blood states more frequently. This study aimed to investigate the effect of COVID-19 on extracorporeal coagulation during CRRT. All CRRT records were gathered from the Hemodialysis Center at our hospital from December 5th, 2022 to February 4th, 2023, and analyzed the incidence and risk factors associated with extracorporeal coagulation. COVID-19 substantially increased the likelihood of extracorporeal coagulation during CRRT. Venous pressure and transmembrane pressure were proportional to the severity of extracorporeal coagulation. Additionally, non-tunnel type conduit vascular access, and acute kidney injury had a positive correlation with the severity of coagulation. Blood tests demonstrated that COVID-19 altered 4 coagulation indices. Moreover, mitigation of coagulation can be achieved through increasing the dosage of low molecular weight heparin and administering regional citrate anticoagulation. Patients who fail anticoagulation may be switched to peritoneal dialysis. In conclusion, COVID-19 poses a heightened risk of extracorporeal coagulation during CRRT. This study underscores the importance of anticoagulant treatment in CRRT for infected patients with kidney failure and holds significant implications for clinical practice. In future, the epidemics of COVID-19 or any other pandemic, the metrics in this study can be referenced to determine coagulation risk, as well as relevant therapeutic practices may be considered.
引用
收藏
页数:8
相关论文
共 43 条
  • [1] Altarawneh HN, 2022, NEW ENGL J MED, V387, P1620, DOI 10.1056/NEJMc2209306
  • [2] Dynamic Characteristics of Blood Platelet Count in COVID-19 Patients
    An, Jiang-Hong
    Qi, Fu-Rong
    Cheng, Xiao-Ya
    Liu, Xun-Qi
    Luo, Pu
    Chen, Qiong
    Qian, Shen
    Zhang, Yi-Hui-Zhi
    Lian, Li
    Guo, Zhi
    Liu, Lei
    Tan, Xiao-Hua
    [J]. JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2022, 12 (04) : 778 - 787
  • [3] [Anonymous], 2022, Diagnosis and treatment guidelines for Lymphoma
  • [4] Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study
    Arnold, Frederic
    Westermann, Lukas
    Rieg, Siegbert
    Neumann-Haefelin, Elke
    Biever, Paul Marc
    Walz, Gerd
    Kalbhenn, Johannes
    Tanriver, Yakup
    [J]. BMC NEPHROLOGY, 2020, 21 (01)
  • [5] Presumed Asymptomatic Carrier Transmission of COVID-19
    Bai, Yan
    Yao, Lingsheng
    Wei, Tao
    Tian, Fei
    Jin, Dong-Yan
    Chen, Lijuan
    Wang, Meiyun
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (14): : 1406 - 1407
  • [6] Dialysis parameters associated with SARS-CoV-2 infection and prognosis in end-stage kidney disease
    Bezerra, Rodrigo
    Feitosa, Audes D. M.
    Silvestre, Odilson M.
    Fernandes-Silva, Miguel M.
    Amazonas, Roberto B.
    Teles, Flavio
    Rodrigues, Cibele I. S.
    Lima-Filho, Jose L.
    Sposito, Andrei C.
    Nadruz Jr, Wilson
    [J]. ANNALS OF MEDICINE, 2024, 56 (01)
  • [7] Critically Ill Patients with COVID-19 Pneumonia Requiring Continuous Renal Replacement Therapy with oXiris® Membrane in a Third-Level Hospital in Northeast Mexico
    Borbolla-Flores, Paola
    Villegas-Gutierrez, Luz Yareli
    Samaniego-Segovia, Bruno Maximiliano
    Torres-Quintanilla, Francisco Javier
    Gomez-Villarreal, Juan Pablo
    Garza-Trevino, Ricardo Abraham
    Rizo-Topete, Lilia Maria
    [J]. BLOOD PURIFICATION, 2024, 53 (08) : 634 - 640
  • [8] Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study
    Canas, Liane S.
    Sudre, Carole H.
    Pujol, Joan Capdevila
    Polidori, Lorenzo
    Murray, Benjamin
    Molteni, Erika
    Graham, Mark S.
    Klaser, Kerstin
    Antonelli, Michela
    Berry, Sarah
    Davies, Richard
    Nguyen, Long H.
    Drew, David A.
    Wolf, Jonathan
    Chan, Andrew T.
    Spector, Tim
    Steves, Claire J.
    Ourselin, Sebastien
    Modat, Marc
    [J]. LANCET DIGITAL HEALTH, 2021, 3 (09): : E587 - E598
  • [9] Dai Tian, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P277
  • [10] Sustained low-efficiency dialysis with regional citrate anticoagulation in critically ill patients with COVID-19 associated AKI: A pilot study
    Di Mario, Francesca
    Regolisti, Giuseppe
    Di Maria, Alessio
    Parmigiani, Alice
    Benigno, Giuseppe Daniele
    Picetti, Edoardo
    Barbagallo, Maria
    Greco, Paolo
    Maccari, Caterina
    Fiaccadori, Enrico
    [J]. JOURNAL OF CRITICAL CARE, 2021, 63 : 22 - 25